Cite
HARVARD Citation
Yang, G. et al. (n.d.). Endogenous interleukin‐22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice. Clinical and experimental immunology. pp. 154-164. [Online].